SCHEMBL18623325

SCHEMBL18623325

c1ccc(-c2cc(-c3ccc(-c4ccc(-c5nc(-c6ccncc6)nc(-c6ccncc6)n5)c5ccccc45)c4ccccc34)nc(-c3ccccc3)n2)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 6/20 0.50
▸ ALDH1A1 P00352 5/20 0.50
▸ MEN1 O00255 5/20 0.50
▸ KMT2A Q03164 5/20 0.50
▸ HPGD P15428 4/20 0.50
▸ MAPK1 P28482 1/20 0.50
▸ KDM4E B2RXH2 4/20 0.48
▸ LMNA P02545 3/20 0.47
▸ RECQL P46063 1/20 0.47
▸ NPSR1 Q6W5P4 1/20 0.47
▸ NTSR1 P30989 1/20 0.46
▸ GLA P06280 1/20 0.44
▸ SQOR Q9Y6N5 1/20 0.44
▸ ADORA2A P29274 1/20 0.44
▸ ADORA1 P30542 1/20 0.44
▸ DHODH Q02127 1/20 0.43
▸ USP2 O75604 1/20 0.43
▸ TSHR P16473 1/20 0.43
▸ GSK3B P49841 1/20 0.42
▸ CDC7 O00311 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18623301 0.97 MAPT (0.53) MAPTALDH1A1MEN1KMT2AHPGD
SCHEMBL24590288 0.95 MAPK1 (0.54) MAPTALDH1A1MEN1KMT2AHPGD
SCHEMBL18623306 0.92 MEN1 (0.58) MAPTALDH1A1MEN1KMT2AHPGD
SCHEMBL23841438 0.91 MEN1 (0.59) MAPTALDH1A1MEN1KMT2AHPGD
SCHEMBL18623309 0.89 MEN1 (0.59) MAPTALDH1A1MEN1KMT2AHPGD
SCHEMBL18623319 0.89 MEN1 (0.59) MAPTALDH1A1MEN1KMT2AHPGD
SCHEMBL18623299 0.89 MEN1 (0.61) MAPTALDH1A1MEN1KMT2AHPGD
SCHEMBL18623323 0.87 CYP3A4 (0.49) MAPTALDH1A1MEN1KMT2AHPGD
SCHEMBL17970034 0.86 MAPT (0.51) MAPTALDH1A1MEN1KMT2AHPGD
SCHEMBL17969926 0.85 ALDH1A1 (0.54) MAPTALDH1A1MEN1KMT2AHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10580994-B2 Compound and organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-03-03 — — US disclosed
US-20170077414-A1 COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-03-16 — — US disclosed
US-20170077414-A1 COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-03-16 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10580994-B2 Compound and organic light-emitting device including the same VDAC1, TMEM109, ELOVL1 MAPT 1518/4885ALDH1A1 124/4885MEN1 1001/4885
US-20170077414-A1 COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME VDAC1, TMEM109, ELOVL1 MAPT 1518/4885ALDH1A1 124/4885MEN1 1001/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback